Evidence map›Paper›PMID 31061049›Full record

ArticleBMJ open2019

Adverse pregnancy outcomes and long-term risk of maternal renal disease: a systematic review and meta-analysis protocol.

Peter M Barrett, Fergus P McCarthy, Karolina Kublickiene, Marie Evans, Sarah Cormican, Conor Judge, Ivan J Perry, Marius Kublickas, Peter Stenvinkel, Ali S Khashan

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Peter M BarrettSchool of Public Health, University College Cork, Cork, Ireland.ORCID 0000-0002-9637-9603
Fergus P McCarthyIrish Centre for Fetal and Neonatal Translational Research, University College Cork, Cork, Ireland.
Karolina KublickieneDepartment of Clinical Sciences Intervention and Technology, Karolinska Institutet, Huddinge, Sweden.
Marie EvansDepartment of Clinical Sciences Intervention and Technology, Karolinska Institutet, Huddinge, Sweden.
Sarah CormicanDepartment of Nephrology, Galway University Hospital, Galway, Ireland.
Conor JudgeDepartment of Nephrology, Galway University Hospital, Galway, Ireland.
Ivan J PerrySchool of Public Health, University College Cork, Cork, Ireland.
Marius KublickasDepartment of Clinical Sciences Intervention and Technology, Karolinska Institutet, Huddinge, Sweden.
Peter StenvinkelDepartment of Clinical Sciences Intervention and Technology, Karolinska Institutet, Huddinge, Sweden.
Ali S KhashanSchool of Public Health, University College Cork, Cork, Ireland.
Karolinska Institutet · SEUniversity College Cork · IEUniversity Hospital Galway · IE

Funding

Wellcome TrustWellcome Trust 203930/B/16/Z
6 · The paper itself

Abstract

introductionAdverse pregnancy outcomes, such as hypertensive disorders of pregnancy (HDP), gestational diabetes (GDM) and preterm birth have been linked to maternal cardiovascular disease in later life. Pre-eclampsia (PE) is associated with an increased risk of postpartum microalbuminuria, but there is no clear consensus on whether HDP increases the risk of maternal chronic kidney disease (CKD) and end-stage kidney disease (ESKD). Similarly, it is uncertain whether GDM, preterm birth and delivery of low birth-weight infants independently predict the risk of maternal renal disease in later life. The aims of this proposed systematic review and meta-analysis are to summarise the available evidence examining the association between adverse outcomes of pregnancy (HDP, GDM, preterm birth, delivery of low birth-weight infant) and later maternal renal disease and to synthesise the results of relevant studies. METHODS AND ANALYSIS: A systematic search of PubMed, EMBASE and Web of Science will be undertaken using a detailed prespecified search strategy. Two authors will independently review the titles and abstracts of all studies, perform data extraction and appraise the quality of included studies using a bias classification tool. Original case-control and cohort studies published in English will be considered for inclusion. Primary outcomes of interest will be CKD and ESKD; secondary outcomes will be hospitalisation for renal disease and deaths from renal disease. Meta-analyses will be performed to calculate the overall pooled estimates using the generic inverse variance method. The systematic review will follow the Meta-analyses Of Observational Studies in Epidemiology guidelines. ETHICS AND DISSEMINATION: This systematic review and meta-analysis will be based on published data, and thus there is no requirement for ethics approval. The results will be shared through publication in a peer reviewed journal and through presentations at academic conferences. PROSPERO REGISTRATION NUMBER: CRD42018110891.

Indexed as

Meta-Analysis as TopicPregnancy ComplicationsPregnancy OutcomeResearch DesignSystematic Reviews as TopicFemaleHumansKidney DiseasesKidney Failure, ChronicPregnancyRenal Insufficiency, ChronicRisk AssessmentTime Factorschronic renal failurediabetes in pregnancyend stage renal failureepidemiologyobstetrics

Identifiers

PMID31061049
PMCPMC6502020
OpenAlexW2943110267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.